Yuta Kaito

Sendagi, 1138602, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Successful Postpartum CAR T-cell Salvage Therapy for Primary Mediastinal Large B-cell Lymphoma with Residual Disease after R-CHOP During Pregnancy.

Successful Postpartum CAR T-cell Salvage Therapy for Primary Mediastinal Large B-cell Lymphoma with Residual Disease after R-CHOP During Pregnancy.

Journal: Internal medicine (Tokyo, Japan)

Published: July 05, 2026

The Effectiveness of Elranatamab in the Management of Refractory Multiple Myeloma with Central Nervous System Involvement.

The Effectiveness of Elranatamab in the Management of Refractory Multiple Myeloma with Central Nervous System Involvement.

Journal: Internal medicine (Tokyo, Japan)

Published: January 14, 2026

Dysphagia after COVID-19 Vaccination: A Report of Two Cases.

Dysphagia after COVID-19 Vaccination: A Report of Two Cases.

Journal: Internal medicine (Tokyo, Japan)

Published: November 12, 2025

Unrelated Bone Marrow Transplantation for Chronic Myeloid Leukemia after Liver Transplantation.

Unrelated Bone Marrow Transplantation for Chronic Myeloid Leukemia after Liver Transplantation.

Journal: Internal medicine (Tokyo, Japan)

Published: February 02, 2025

Evolution of natural killer cell-targeted therapy for acute myeloid leukemia.

Evolution of natural killer cell-targeted therapy for acute myeloid leukemia.

Journal: International journal of hematology

Published: March 15, 2024

Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.

Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.

Journal: Haematologica

Published: February 08, 2023

Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia.

Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia.

Journal: Communications biology

Published: September 20, 2022

The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma.

The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma.

Journal: Experimental hematology

Published: August 10, 2022

Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Internal medicine (Tokyo, Japan)

Published: October 18, 2021

CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia.

CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia.

Journal: Oncology letters

Published: September 21, 2021

Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.

Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.

Journal: International journal of clinical oncology

Published: May 15, 2021

Safety and efficacy of high-dose cytarabine MEAM therapy and other treatments for auto-peripheral blood stem cell transplantation: A retrospective comparative study.

Safety and efficacy of high-dose cytarabine MEAM therapy and other treatments for auto-peripheral blood stem cell transplantation: A retrospective comparative study.

Journal: Asia-Pacific journal of clinical oncology

Published: May 02, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026